Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses

被引：1
作者：
Li, Zijun [1 ,2 ]
Lee, Joo-Eun [2 ]
Cho, Namki [2 ]
Yoo, Hee Min [1 ,3 ]
机构：
[1] Korea Res Inst Stand & Sci KRISS, Biometrol Grp, Daejeon 34113, South Korea
[2] Chonnam Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Gwangju 61186, South Korea
[3] Univ Sci & Technol UST, Dept Precis Measurement, Daejeon 34113, South Korea
来源：
HELIYON | 2023年 / 9卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
Natural products; SARS-CoV-2; Pseudotyped viruses; Antiviral activity; Reactive oxygen species; USNIC ACID; HOSPITALIZED-PATIENTS; USNEA-BARBATA; IN-VITRO; TOCILIZUMAB; ANTIFUNGAL; EXTRACTS;
D O I：
10.1016/j.heliyon.2023.e21742
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The escalating pandemic brought about by the novel SARS-CoV-2 virus is threatening global health, and thus, it is necessary to develop effective antiviral drugs. Usenamine A is a dibenzofuran derivative separated from lichen Usnea diffracta showing broad-spectrum activity against different viruses. We evaluate that usenamine A has antiviral effects against novel SARS-CoV-2 Delta variant pseudotyped viruses (PVs) in A549 cells. In addition, usenamine A significantly suppresses SARS-CoV-2 PV-induced mitochondrial depolarization, elevated reactive oxygen species (ROS) levels, apoptosis, and inflammation. Usenamine A also causes the SARS-CoV-2 spike protein to become less stable. Thus, usenamine A shows potential as an antiviral drug that can provide protection against COVID-19.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences
    Abramenko, Nikita
    Vellieux, Frederic
    Tesarova, Petra
    Kejik, Zdenek
    Kaplanek, Robert
    Lacina, Lukas
    Dvorankova, Barbora
    Rosel, Daniel
    Brabek, Jan
    Tesar, Adam
    Jakubek, Milan
    Smetana, Karel, Jr.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [22] Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2
    Jamshidi, Zahra
    Hashemi, Maryam
    Yazdian-Robati, Rezvan
    Etemad, Leila
    Salmasi, Zahra
    Kesharwani, Prashant
    INFLAMMOPHARMACOLOGY, 2022, 30 (05) : 1541 - 1553
  • [23] Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
    Singh, Anamika
    Arkin, Isaiah T.
    PHARMACEUTICALS, 2022, 15 (04)
  • [24] Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
    Yarovaya, Olga I.
    Shcherbakov, Dmitriy N.
    Borisevich, Sophia S.
    Sokolova, Anastasiya S.
    Gureev, Maxim A.
    Khamitov, Edward M.
    Rudometova, Nadezda B.
    Zybkina, Anastasiya V.
    Mordvinova, Ekaterina D.
    Zaykovskaya, Anna V.
    Rogachev, Artem D.
    Pyankov, Oleg V.
    Maksyutov, Rinat A.
    Salakhutdinov, Nariman F.
    VIRUSES-BASEL, 2022, 14 (06):
  • [25] Antiviral effect of electrolyzed reduced water on SARS-CoV-2
    Okajima, Yoshinao
    Okajima, Masahiro
    Ikeda, Mitsuo
    Wada, Yuko
    Shimokawa, Ken-Ichi
    Ishii, Fumiyoshi
    DRUG DISCOVERIES AND THERAPEUTICS, 2021, 15 (05) : 268 - 272
  • [26] Reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19
    Guimaraes, Taisa Coelho
    Fagundes Marques, Barbara Bruno
    de Castro, Marcelle Viana
    Secco, Daniele Angst
    Moraes Sobrino Porto, Luis Cristovao
    Monnerat Tinoco, Justine Monteiro
    Barretto Tinoco, Eduardo Muniz
    Fletcher, Paul
    Fischer, Ricardo Guimaraes
    ORAL DISEASES, 2022, 28 : 2474 - 2480
  • [27] Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection
    Dezza, F. Cogliati
    Oliva, A.
    Cancelli, F.
    Savelloni, G.
    Valeri, S.
    Mauro, V.
    Calabretto, M.
    Russo, G.
    Venditti, M.
    Turriziani, O.
    Mastroianni, C. M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 100 (02)
  • [28] Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
    Gentile, Davide
    Chiummiento, Lucia
    Santarsiere, Alessandro
    Funicello, Maria
    Lupattelli, Paolo
    Rescifina, Antonio
    Venuti, Assunta
    Piperno, Anna
    Sciortino, Maria Teresa
    Pennisi, Rosamaria
    VIRUSES-BASEL, 2024, 16 (03):
  • [29] Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2
    Anand, Arumugam Vijaya
    Balamuralikrishnan, Balasubramanian
    Kaviya, Mohandass
    Bharathi, Kathirvel
    Parithathvi, Aluru
    Arun, Meyyazhagan
    Senthilkumar, Nachiappan
    Velayuthaprabhu, Shanmugam
    Saradhadevi, Muthukrishnan
    Al-Dhabi, Naif Abdullah
    Arasu, Mariadhas Valan
    Yatoo, Mohammad Iqbal
    Tiwari, Ruchi
    Dhama, Kuldeep
    MOLECULES, 2021, 26 (06):
  • [30] Role of Diet and Nutrients in SARS-CoV-2 Infection: Incidence on Oxidative Stress, Inflammatory Status and Viral Production
    Brahmi, Fatiha
    Vejux, Anne
    Ghzaiel, Imen
    Ksila, Mohamed
    Zarrouk, Amira
    Ghrairi, Taoufik
    Essadek, Soukena
    Mandard, Stephane
    Leoni, Valerio
    Poli, Giuseppe
    Vervandier-Fasseur, Dominique
    Kharoubi, Omar
    El Midaoui, Adil
    Atanasov, Atanas G.
    Meziane, Smail
    Latruffe, Norbert
    Nasser, Boubker
    Bouhaouala-Zahar, Balkiss
    Masmoudi-Kouki, Olfa
    Madani, Khodir
    Boulekbache-Makhlouf, Lila
    Lizard, Gerard
    NUTRIENTS, 2022, 14 (11)
12345